Bristol-Myers Squibb Company (BMY) Insider Trading
- $16,128,860.71
- $516,791,419.91
- Nov. 4, 2024
- Lamberto Andreotti
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 7, 2019 | Director | 23,466 | $87.29 | Sell | $2,048,347.14 | |
| Aug. 9, 2018 | Director | 12,000 | $92.32 | Sell | $1,107,840.00 | |
| Aug. 7, 2018 | Director | 5,575 | $89.73 | Buy | $500,244.75 | |
| June 7, 2018 | Director | 13,000 | $78.77 | Sell | $1,024,010.00 | |
| June 4, 2018 | Director | 17,750 | $78.96 | Sell | $1,401,540.00 | |
| May 18, 2018 | Director | 27,750 | $78.66 | Sell | $2,182,815.00 | |
| May 9, 2018 | CEO | 1,208 | $82.60 | Buy | $99,780.80 | |
| April 30, 2018 | Director | 4,770 | $52.40 | Buy | $249,948.00 | |
| March 12, 2018 | Director | 9,250 | $92.01 | Sell | $851,092.50 | |
| Feb. 23, 2018 | Director | 13,370 | $94.49 | Sell | $1,263,331.30 | |
| Feb. 20, 2018 | Director | 9,250 | $94.83 | Sell | $877,177.50 | |
| Feb. 15, 2018 | Director | 9,250 | $95.99 | Sell | $887,907.50 | |
| Feb. 8, 2018 | Insider | 3,260 | $91.90 | Buy | $299,594.00 | |
| Dec. 15, 2017 | Director | 4,000 | $62.30 | Buy | $249,200.00 | |
| Dec. 12, 2017 | EVP | 5,300 | $63.24 | Sell | $335,172.00 | |
| Dec. 4, 2017 | EVP | 156,582 | $63.37 | Sell | $9,922,601.34 | |
| Sept. 25, 2017 | Insider | 1,727 | $143.89 | Sell | $248,498.03 | |
| Sept. 12, 2017 | Director | 9,250 | $141.56 | Sell | $1,309,430.00 | |
| Sept. 6, 2017 | SVP | 9,340 | $60.00 | Sell | $560,400.00 | |
| Sept. 5, 2017 | Director | 9,250 | $139.03 | Sell | $1,286,027.50 | |
| Aug. 10, 2017 | Director | 18,506 | $130.52 | Sell | $2,415,403.12 | |
| Aug. 2, 2017 | Director | 6,000 | $55.94 | Buy | $335,640.00 | |
| Aug. 2, 2017 | Director | 7,500 | $134.52 | Sell | $1,008,900.00 | |
| June 26, 2017 | Director | 18,500 | $133.57 | Sell | $2,471,045.00 | |
| June 22, 2017 | Insider | 175,970 | $134.14 | Sell | $23,604,615.80 | |
| June 22, 2017 | Director | 10,000 | $132.50 | Sell | $1,325,000.00 | |
| June 21, 2017 | Director | 9,250 | $133.05 | Sell | $1,230,712.50 | |
| June 19, 2017 | Director | 9,250 | $125.59 | Sell | $1,161,707.50 | |
| June 15, 2017 | Insider | 4,785 | $120.18 | Sell | $575,061.30 | |
| May 1, 2017 | Director | 9,250 | $124.00 | Sell | $1,147,000.00 | |
| April 7, 2017 | Director | 34,000 | $53.26 | Sell | $1,810,840.00 | |
| March 30, 2017 | Director | 14,033 | $123.83 | Sell | $1,737,706.39 | |
| March 28, 2017 | Director | 34,000 | $56.17 | Sell | $1,909,780.00 | |
| March 27, 2017 | Director | 17,000 | $56.14 | Sell | $954,380.00 | |
| March 17, 2017 | Insider | 5,000 | $56.49 | Sell | $282,450.00 | |
| March 15, 2017 | SVP | 8,096 | $57.29 | Sell | $463,819.84 | |
| March 6, 2017 | EVP | 92,405 | $57.02 | Sell | $5,268,933.10 | |
| March 1, 2017 | Insider | 4,000 | $124.42 | Sell | $497,680.00 | |
| Feb. 27, 2017 | Director | 12,000 | $56.77 | Buy | $681,240.00 | |
| Nov. 9, 2016 | Director | 18,600 | $116.10 | Sell | $2,159,460.00 | |
| Oct. 24, 2016 | Major Shareholder | 800,150 | $14.00 | Buy | $11,202,100.00 | |
| Oct. 3, 2016 | Director | 56,116 | $103.66 | Sell | $5,816,984.56 | |
| Sept. 23, 2016 | Director | 20,000 | $110.82 | Sell | $2,216,400.00 | |
| Sept. 15, 2016 | Director | 9,710 | $106.44 | Sell | $1,033,532.40 | |
| Sept. 8, 2016 | Director | 21,600 | $56.87 | Sell | $1,228,392.00 | |
| Aug. 25, 2016 | Director | 23,200 | $59.17 | Sell | $1,372,744.00 | |
| Aug. 23, 2016 | Director | 27,500 | $114.10 | Sell | $3,137,750.00 | |
| Aug. 22, 2016 | Director | 43,134 | $114.01 | Sell | $4,917,707.34 | |
| July 28, 2016 | Insider | 100,000 | $110.00 | Sell | $11,000,000.00 | |
| July 8, 2016 | Director | 23,200 | $74.45 | Sell | $1,727,240.00 |
Insiders are both buying and selling Bristol-Myers Squibb Company stock.
The insider traders at Bristol-Myers Squibb Company are: Lamberto Andreotti, Giovanni Caforio, Gilla Kaplan, James M Cornelius, Ernest Mario, Rupert Vessey, Sandra Leung, Louis S Schmukler, Joseph C Caldarella, James J Loughlin, Michael D Casey, Autenried Paul Von, John E Elicker, Theodore R Samuels II, Robert J Hugin, Ann Powell, Samuel J Moed, Charles A Bancroft, Beatrice J Cazala, Adam Dubow, Mark J Alles, Michael A Friedman, Christopher S Boerner, Joseph Eid, Karen Murphy Santiago, David V Elkins, Lewis B Campbell, Dinesh C Paliwal, Louis Schmukler, Perry A Karsen, James Cornelius, Michael D. Casey, Thomas O Daniel, Terrie Curran, Richard W Barker, Joseph Caldarella, Francis M Cuss, Samit Hirawat, Carrie Smith Cox, Charles Bancroft, Corp /De/ Celgene, Elliot Sigal, Francis Cuss, John Elicker, John H Weiland, Lawrence Stein, Lawrence V Stein, Lewis Campbell, Michael Casey, Michael W Bonney, Perry Karsen, Phil M Holzer, Robert J Bertolini, Robert M Plenge, Thomas Daniel, and Thomas J Jr. Lynch
The most active insider trader at Bristol-Myers Squibb Company is Lamberto Andreotti with 27 trades.
Robert J Hugin has sold the most Bristol-Myers Squibb Company stock with a total value of $90,990,863.06.
Corp /De/ Celgene has bought the most Bristol-Myers Squibb Company stock with a total value of $22,404,200.00.
The most recent insider trade for Bristol-Myers Squibb Company was on Nov. 4, 2024.
The single biggest insider buy for Bristol-Myers Squibb Company was from Corp /De/ Celgene with a total value of $11,202,100.00 on Oct. 24, 2016.
The single biggest insider sell for Bristol-Myers Squibb Company was from Robert J Hugin with a total value of $23,604,615.80 on June 22, 2017.